- Home
- TRVI vs REAX Comparison
TRVI vs REAX Comparison
Compare TRVI & REAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRVI
- REAX
- Stock Information
- Founded
- TRVI 2011
- REAX 2018
- Country
- TRVI United States
- REAX United States
- Employees
- TRVI N/A
- REAX N/A
- Industry
- TRVI Biotechnology: Pharmaceutical Preparations
- REAX
- Sector
- TRVI Health Care
- REAX
- Exchange
- TRVI Nasdaq
- REAX Nasdaq
- Market Cap
- TRVI 1.1B
- REAX 937.7M
- IPO Year
- TRVI 2019
- REAX N/A
- Fundamental
- Price
- TRVI $9.64
- REAX $4.11
- Analyst Decision
- TRVI Strong Buy
- REAX Strong Buy
- Analyst Count
- TRVI 9
- REAX 3
- Target Price
- TRVI $20.72
- REAX $6.33
- AVG Volume (30 Days)
- TRVI 2.6M
- REAX 2.3M
- Earning Date
- TRVI 11-05-2025
- REAX 10-30-2025
- Dividend Yield
- TRVI N/A
- REAX N/A
- EPS Growth
- TRVI N/A
- REAX N/A
- EPS
- TRVI N/A
- REAX N/A
- Revenue
- TRVI N/A
- REAX $1,617,846,000.00
- Revenue This Year
- TRVI N/A
- REAX $52.77
- Revenue Next Year
- TRVI N/A
- REAX $19.10
- P/E Ratio
- TRVI N/A
- REAX N/A
- Revenue Growth
- TRVI N/A
- REAX 72.57
- 52 Week Low
- TRVI $2.36
- REAX $3.80
- 52 Week High
- TRVI $10.16
- REAX $6.61
- Technical
- Relative Strength Index (RSI)
- TRVI 64.43
- REAX 33.83
- Support Level
- TRVI $8.24
- REAX $3.97
- Resistance Level
- TRVI $8.65
- REAX $5.16
- Average True Range (ATR)
- TRVI 0.51
- REAX 0.19
- MACD
- TRVI 0.10
- REAX -0.10
- Stochastic Oscillator
- TRVI 76.06
- REAX 12.18
About TRVI Trevi Therapeutics Inc.
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.
About REAX The Real Brokerage Inc.
The Real Brokerage Inc is a technology-powered real estate brokerage firm located in the United States and Canada. It has developed a proprietary transaction management and brokerage operations software called reZEN, which powers nearly all of its brokerage operations, enabling efficiency, automation, and flexibility by incorporating end-to-end transaction management, automated compliance and brokerage oversight, integrated payments and financial services, Leo CoPilot, and open API for customization. In addition, the company also offers mortgage brokering and title services. The company's operating segments are North American Brokerage, which derives key revenue, One Real Title, One Real Mortgage, and Real Wallet. Geographically, it derives key revenue from the United States.